Literature DB >> 24179702

FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.

Voichita Bar-Ad1, Wenyin Shi, Madalina Tuluc, Nitin Ohri, David Cognetti, Joseph Curry, Charles Intenso.   

Abstract

OBJECTIVES: The objective of the current review was to use published data to assess the role of [18F] fluorodeoxyglucose-positron emission tomography (FDG-PET) as a complementary modality to computed-tomography (CT) in radiotherapy target volume delineation for head and neck cancer (HNC).
METHODS: Studies were identified by searching PubMed electronic databases. Both prospective and retrospective studies were included. Information regarding the role of FDG-PET for radiotherapy target volume delineation for HNC was analyzed.
RESULTS: FDG-PET is a promising tool for improving radiotherapy target volume delineation by defining a metabolically active biological target volume (BTV). The use of novel PET tracers representing properties such as hypoxia, protein synthesis and proliferation remain to be better characterized.
CONCLUSIONS: The role of FDG-PET for radiotherapy target volume delineation for patients with HNC is expanding and should be further evaluated in clinical trials.

Entities:  

Keywords:  FDG-PET; Head and neck cancer; Radiotherapy target volumes

Year:  2012        PMID: 24179702      PMCID: PMC3811146          DOI: 10.4172/2155-9619.1000124

Source DB:  PubMed          Journal:  J Nucl Med Radiat Ther


  55 in total

1.  FDG-PET in radiotherapy treatment planning: Pandora's box?

Authors:  Arnold C Paulino; Peter A S Johnstone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

2.  Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck.

Authors:  Ann Dorothy King; Kunwar Suryaveer Singh Bhatia
Journal:  World J Radiol       Date:  2010-05-28

3.  Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort?

Authors:  Pierre Castadot; Xavier Geets; John Aldo Lee; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2011-07-01       Impact factor: 6.280

4.  A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.

Authors:  Mitsuhiko Hasebe; Kyosan Yoshikawa; Seiya Ohashi; Sachiko Toubaru; Koji Kawaguchi; Junichi Sato; Junetsu Mizoe; Hirohiko Tsujii
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

5.  Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.

Authors:  Stephen L Breen; Julia Publicover; Shiroma De Silva; Greg Pond; Kristy Brock; Brian O'Sullivan; Bernard Cummings; Laura Dawson; Anne Keller; John Kim; Jolie Ringash; Eugene Yu; Aaron Hendler; John Waldron
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

6.  Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Authors:  Morand Piert; Hans-Jürgen Machulla; Maria Picchio; Gerald Reischl; Sybille Ziegler; Piyush Kumar; Hans-Jürgen Wester; Roswitha Beck; Alexander J B McEwan; Leonard I Wiebe; Markus Schwaiger
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

7.  Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.

Authors:  Mark K Wax; Larry L Myers; Edward C Gabalski; Syed Husain; Jayakumari M Gona; Hani Nabi
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-06

8.  Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.

Authors:  John D Fenwick; Juan Pardo-Montero; Alan E Nahum; Zafar I Malik
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

9.  Staging of head and neck squamous cell cancer with extended-field FDG-PET.

Authors:  David L Schwartz; Joseph Rajendran; Bevan Yueh; Marc Coltrera; Yoshimi Anzai; Kenneth Krohn; Janet Eary
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-11

10.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.

Authors:  Daniela Thorwarth; Susanne-Martina Eschmann; Jutta Scheiderbauer; Frank Paulsen; Markus Alber
Journal:  BMC Cancer       Date:  2005-12-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.